Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy
Najibeh Shekari, Dariush Shanehbandi, Tohid Kazemi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 25

Showing 25 citing articles:

Intracellular and extracellular activities of V-domain Ig-containing suppressor of T cell activation (VISTA) modulated by immunosuppressive factors of tumour microenvironment
Maryam Abooali, Stephanie Schlichtner, Lei Xi, et al.
Cancer Letters (2025), pp. 217581-217581
Open Access | Times Cited: 1
The VISTA/VSIG3/PSGL-1 axis: crosstalk between immune effector cells and cancer cells in invasive ductal breast carcinoma
Mateusz Olbromski, Monika Mrozowska, Aleksandra Piotrowska, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 8
Open Access | Times Cited: 4
Single-cell transcriptomics unveils multifaceted immune heterogeneity in early-onset versus late-onset cervical cancer
Qian Chen, Dongfeng Deng, Hong Zhu, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Small molecules targeting immune checkpoint proteins for cancer immunotherapy: a patent and literature review (2020-2024)
Qiaohong Geng, Juanjuan Xu, Cheng Du, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Chidamide functions as a VISTA/PSGL-1 blocker for cancer immunotherapy
Xiaoshuang Niu, Wenshan Zhao, Xiuman Zhou, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
PD-1H (VISTA) expression in cutaneous squamous cell carcinoma is correlated with T cell infiltration and activation
Michal Kidacki, Christina Cho, Francesc López‐Giráldez, et al.
Journal of Investigative Dermatology (2025)
Closed Access
Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy
Saud Almawash
Cancers (2025) Vol. 17, Iss. 5, pp. 880-880
Open Access
Targeting novel immune checkpoints in the B7-H family: advancing cancer immunotherapy from bench to bedside
Yiming Luo, Ye Yuan, Shilin Liu, et al.
Trends in cancer (2025)
Open Access
Immune inhibitory receptor agonist therapeutics
Rustin R. Lovewell, Solomon Langermann, Dallas B. Flies
Frontiers in Immunology (2025) Vol. 16
Open Access
Immune checkpoint for pregnancy
Xiaohui Hu, Siying Lai, Aihua Liao
Seminars in Immunopathology (2025) Vol. 47, Iss. 1
Closed Access
Inhibitory immune checkpoints suppress the surveillance of senescent cells promoting their accumulation with aging and in age-related diseases
Antero Salminen
Biogerontology (2024) Vol. 25, Iss. 5, pp. 749-773
Open Access | Times Cited: 3
VISTA: A promising target for overcoming immune evasion in gynecologic cancers
Sicong Liu, Feng Ji, Yue Ding, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112655-112655
Closed Access | Times Cited: 3
A functional role for glycosylated B7-H5/VISTA immune checkpoint protein in metastatic clear cell renal cell carcinoma
Maite Emaldi, Paula Alamillo-Maeso, Esther Rey-Iborra, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110587-110587
Open Access | Times Cited: 2
The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer’s disease
Antero Salminen
Journal of Molecular Medicine (2024)
Open Access | Times Cited: 2
Small Molecule Inhibitors Targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for Cancer Immunotherapy (2020-2024)
Binbin Cheng, Jiaoli Lv, Yao Xiao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117141-117141
Closed Access | Times Cited: 2
VISTA deficiency exerts anti-tumor effects in breast cancer through regulating macrophage polarization
Shasha Jin, Wanmei Liu, Xiaoyu He, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112365-112365
Closed Access | Times Cited: 1
Immune Checkpoint Inhibitors: Novel Therapies and Targets
Elen Baloyan, Amalya Sargsyan, Karen Bedirian, et al.
Interdisciplinary cancer research (2024)
Closed Access
VISTA‐targeted antibody‐drug conjugates exhibit potent antitumor effects on malignant pleural mesothelioma
Jingyue Kang, Zongliang Zhang, Ruyuan Zhang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 2
Open Access
Immune Checkpoint Inhibitors in Cancer Immunotherapy
Fathima Hasnain Nadeem Hussain, Afsheen Raza
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 123-156
Closed Access
Review of immunotherapy in non-small cell lung cancer: mechanisms, clinical applications, and future prospects
Palwasha Habib
Asia-Pacific Journal of Oncology (2024)
Open Access
Small-Molecule Radiotracers for Visualization of V-Domain Immunoglobulin Suppressor of T Cell Activation
Jia Liu, Yuanyuan Liang, Hongzhang Yang, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
VSIG-3/IGSF11 silencing in A2058 melanoma cells simultaneously suppresses melanoma progression and induces anti-tumoral cytokine profile in human T cells: In silico and in vitro study
Najibeh Shekari, Dariush Shanehbandi, Elham Baghbani, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Biomarkers to predict the benefits of immune‑checkpoint blockade‑based therapy in patients with malignant peritoneal mesothelioma (Review)
Chunhong Wang, Yan Zhao, Wanru Liang
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access
The Diverse Roles of the Tumour Microenvironment in Carcinogenesis
Ismail Ibrahim Al-Janabi
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2024) Vol. 7, Iss. 2, pp. 26-37
Open Access
Mapping the Binding Hotspots and Transient Binding Pockets on V-Domain Immunoglobulin Suppressor of T Cell Activation Protein Surface
Bingjie Li, Lixiu Xu, Chen Chu, et al.
ACS Omega (2024) Vol. 9, Iss. 49, pp. 48657-48669
Closed Access
Page 1

Scroll to top